Navigating the New Era in Myelodysplastic Neoplasms: A Review of Prognostic Implications of the IPSS-M Score and 2022 WHO Classification. [PDF]
Lapadat ME +4 more
europepmc +1 more source
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States. [PDF]
Lachowiez CA +31 more
europepmc +1 more source
Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on <i>U2AF1</i>. [PDF]
Park MS +5 more
europepmc +1 more source
TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes [PDF]
et al, +8 more
core +2 more sources
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]
Hong J.
europepmc +1 more source
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations. [PDF]
Hebeda KM +10 more
europepmc +1 more source
Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q Region. [PDF]
Testa U, Castelli G, Pelosi E.
europepmc +1 more source

